Teva reaches $925,000 settlement to resolve drug price-fixing claims

Teva was among a group of 20 pharma companies cited in the lawsuit, alongside Novartis’ Sandoz Unit, Mylan, Pfizer and others.

Back to the future

business. The ancestors of these business model genera could already be seen in, for example, Roche, Mylan and Fresenius but in each case we have seen increasing specialisation and, consequently, differentiation.

Pfizer's basic instincts

It happened to coincide with a blizzard of emails from friends who work for parts of Pfizer or for Mylan and now have Viatris.com addresses. ... At the same time, the welding of Mylan and Pfizer’s Upjohn business was accompanied with press release

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU

The Patent Trial and Appeal Board – run by the US Patent and Trademark Office – determined that Mylan did not sufficiently demonstrate its claim and dismissed the challenge. ... Circuit to remove this patent from blocking generic competition to

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]